Valuation: Biosenta Inc.

Market Cap 1.51M 1.08M 965K 892K 808K 102M 1.53M 10.67M 4.25M 53.6M 4.04M 3.95M 170M P/E 2024
-1.19x
P/E 2025 -1.59x
Enterprise Value 8.12M 5.78M 5.19M 4.8M 4.34M 551M 8.22M 57.36M 22.85M 288M 21.7M 21.24M 915M EV / Sales 2024
6,101x
EV / Sales 2025 8,809x
Free-Float
86.62%
Yield 2024 *
-
Yield 2025 -
Current month+100.00%
1 month+100.00%
3 months+14.29%
6 months+60.00%
Current year-20.00%
1 month 0.04
Extreme 0.04
0.09
Current year 0.01
Extreme 0.01
0.12
1 year 0.01
Extreme 0.01
0.13
3 years 0.01
Extreme 0.01
0.89
5 years 0.01
Extreme 0.01
0.89
10 years 0
Extreme 0
2.5
Manager TitleAgeSince
Chief Executive Officer - 15/07/2019
Director TitleAgeSince
Chairman 65 16/02/2015
Director/Board Member - 31/10/2016
Chairman 90 15/07/2019
Date Insider Type Main position Quantity % Market Cap. Importance
02/05/26 Option

Chief Executive Officer

-210,000 0.6040%
02/05/26 Option

Director

-807,000 2.3210%
03/03/26 Option

Chief Executive Officer

625,000 1.8139%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-36.00%-75.76% 2.15M
+0.11%-3.79%-14.77%-9.48% 44.1B
-0.25%-0.21%+24.35%+15.45% 24.91B
+0.85%+2.47%-24.61%-25.47% 10.56B
+0.30%+1.81%-2.70%-9.18% 4.84B
-2.24%-5.05%+14.84%+23.78% 3.21B
+0.72%+2.18%-48.15%-64.70% 2.92B
-2.07%+11.15%+5.87%+0.59% 2.93B
0.00%-1.74%-16.83%+12.11% 1.88B
-0.53%+1.69%-11.13%+44.37% 1.26B
Average -0.42%-0.29%-10.91%-8.83% 9.66B
Weighted average by Cap. -0.16%-2.61%-4.55%-3.93%

Financials

2024 2025
Net sales 1.38K 982.52 881.52 815 738.12 93.58K 1.4K 9.74K 3.88K 48.97K 3.69K 3.61K 155K 1.21K 862.82 774.13 715.71 648.2 82.18K 1.23K 8.56K 3.41K 43K 3.24K 3.17K 137K
Net income -2.23M -1.59M -1.42M -1.32M -1.19M -151M -2.25M -15.74M -6.27M -79.1M -5.96M -5.83M -251M -2.51M -1.79M -1.6M -1.48M -1.34M -170M -2.54M -17.71M -7.05M -88.98M -6.7M -6.56M -282M
Net Debt 5.54M 3.95M 3.54M 3.28M 2.97M 376M 5.61M 39.17M 15.6M 197M 14.82M 14.51M 625M 6.61M 4.71M 4.22M 3.91M 3.54M 448M 6.69M 46.69M 18.6M 235M 17.67M 17.29M 745M
Projected Income Statement - Annual - Biosenta Inc.
Logo Biosenta Inc.
Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and industrial applications, utilizing advanced encapsulated nanotechnology. It develops antimicrobial products that offer environmentally friendly solutions to a global market. Its flagship product, Tri-Filler, represents an antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi. Tri-filler's Nano-technology particles provide anti-microbial protection while preventing the growth of mold, bacteria and viruses. Tri-filler can be embedded to protect various materials, including drywall, plastic and resin, from microbe formation. These compounds remain active for decades and protect the drywall of buildings, objects such as resin furniture, carpet rubber backing and synthetic tufts containing plastic, resin, textiles and others. Its true disinfectant is recognized by Health Canada for use in the fight against COVID-19.
Employees
-
Date Price Change Volume
28/10/26 CA$0.0800 0.00% 59,220